A detailed history of Dauntless Investment Group, LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Dauntless Investment Group, LLC holds 70,848 shares of NVNO stock, worth $242,300. This represents 0.22% of its overall portfolio holdings.

Number of Shares
70,848
Holding current value
$242,300
% of portfolio
0.22%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025

BUY
$2.63 - $3.77 $186,330 - $267,096
70,848 New
70,848 $186 Million

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $32.4M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track This Portfolio

Track Dauntless Investment Group, LLC Portfolio

Follow Dauntless Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dauntless Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dauntless Investment Group, LLC with notifications on news.